银杏叶提取物联合常规治疗老年急性脑梗死疗效观察

发布时间：2018-09-17 16:19

【摘要】：目的:探讨银杏叶提取物联合常规治疗老年急性脑梗死的临床疗效。方法:老年急性脑梗死患者65例随机分为观察组和对照组。对照组患者给予常规治疗;观察组患者在此基础上加用银杏叶提取物。两组疗程均为3周。采用神经功能缺损评分(NHISS)评定两组疗效;比较两组患者治疗前后简易智力状态检查量表(MMSE)、日常生活能力量表(ADL)、凝血功能及血流动力学指标变化。结果:观察组总有效率为84.85%,明显高于对照组的62.50%(P0.05)。治疗后,两组MMSE评分和ADL评分值均较前明显提高(P0.05),且观察组两项评分均优于对照组(P0.05)。治疗后,两组凝血功能与血液流变学各项指标均较前明显改善(P0.05),且观察组各项指标均优于对照组(P0.05)。结论:银杏叶提取物治疗老年性急性脑梗死疗效更显著,不良反应少,值得在临床中推广。
[Abstract]:Objective: to investigate the clinical effect of ginkgo biloba extract combined with routine therapy in elderly patients with acute cerebral infarction. Methods: 65 elderly patients with acute cerebral infarction were randomly divided into observation group and control group. The patients in the control group were treated with routine therapy, and the patients in the observation group were treated with ginkgo biloba extract. The course of treatment was 3 weeks in both groups. (NHISS) was used to evaluate the efficacy of the two groups and to compare the changes of coagulation function and hemodynamics of (ADL), before and after treatment with the mini-mental state examination scale (MMSE),) and the activity of daily living scale (ADL),). Results: the total effective rate of the observation group was 84.85, which was significantly higher than that of the control group (62.50%, P0.05). After treatment, the MMSE scores and ADL scores of the two groups were significantly higher than those of the former (P0.05), and the two scores in the observation group were better than those in the control group (P0.05). After treatment, the coagulation function and hemorheology of the two groups were significantly improved (P0.05), and the observation group was better than the control group (P0.05). Conclusion: ginkgo biloba extract is more effective in the treatment of senile acute cerebral infarction and has less adverse reactions, so it is worth popularizing in clinic.
【作者单位】：无锡市人民医院;
【分类号】：R743.33

【相似文献】